Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02692 | 34280515 | Adv Drug Deliv Rev | Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. | 2021 | Details |
| A02699 | 34278728 | Physiol Rep | Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study. | 2021 | Details |
| A02703 | 34277974 | Endocrinol Diabetes Metab | Impact of lifestyle Intervention on branched-chain amino acid catabolism and insulin sensitivity in adolescents with obesity. | 2021 | Details |
| A02708 | 34277236 | Cureus | The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A02709 | 34276380 | Front Pharmacol | Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1. | 2021 | Details |
| A02711 | 34276221 | Diabetes Metab Syndr Obes | Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02714 | 34276153 | J Clin Exp Hepatol | Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link? | 2020 | Details |
| A02719 | 34274649 | Environ Pollut | Comparative effects of genistein and bisphenol A on non-alcoholic fatty liver disease in laying hens. | 2021 | Details |
| A02724 | 34273192 | J Gastroenterol Hepatol | Insulin-like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease. | 2021 | Details |
| A02731 | 34269508 | J Clin Hypertens (Greenwich) | Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease. | 2021 | Details |
| A02750 | 34260600 | PLoS One | Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease. | 2021 | Details |
| A02751 | 34260003 | Neurochem Res | Resveratrol Protects SH-SY5Y Cells Against Oleic Acid-Induced Glucolipid Metabolic Dysfunction and Cell Injuries Via the Wnt/β-Catenin Signalling Pathway. | 2021 | Details |
| A02756 | 34257817 | Oxid Med Cell Longev | The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence. | 2021 | Details |
| A02757 | 34257694 | Evid Based Complement Alternat Med | Alleviative Effect of Ruellia tuberosa L. on Insulin Resistance and Abnormal Lipid Accumulation in TNF-α-Treated FL83B Mouse Hepatocytes. | 2021 | Details |
| A02758 | 34257427 | Nat Rev Gastroenterol Hepatol | Dietary carbohydrates and fats in nonalcoholic fatty liver disease. | 2021 | Details |
| A02761 | 34255575 | Metab Syndr Relat Disord | Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey. | 2021 | Details |
| A02766 | 34251802 | J Agric Food Chem | Oleanolic Acid Targets the Gut-Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis. | 2021 | Details |
| A02770 | 34249975 | Front Med (Lausanne) | Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD. | 2021 | Details |
| A02776 | 34246549 | Hepatobiliary Pancreat Dis Int | The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China. | 2021 | Details |
| A02777 | 34245170 | J Food Biochem | Ziziphus spina-christi (L.) fortified with Camellia sinensis mediates apoptosis, Notch-1 signaling, and mitigates obesity-induced non-alcoholic fatty liver. | 2021 | Details |
| A02788 | 34239714 | Oman Med J | Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials. | 2021 | Details |
| A02805 | 34234198 | Sci Rep | Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. | 2021 | Details |
| A02818 | 34231324 | Physiol Rep | Crosstalk between beta-adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high-fat diet-fed male mice. | 2021 | Details |
| A02831 | 34226120 | Nutr Metab Cardiovasc Dis | Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes. | 2021 | Details |
| A02847 | 34221261 | Gastroenterol Hepatol Bed Bench | The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study. | 2021 | Details |
| A02848 | 34220701 | Front Endocrinol (Lausanne) | Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. | 2021 | Details |
| A02850 | 34219361 | Liver Int | PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. | 2021 | Details |
| A02857 | 34214406 | Expert Opin Investig Drugs | Anti-diabetic drugs and NASH: from current options to promising perspectives. | 2021 | Details |
| A02861 | 34213749 | Indian J Gastroenterol | Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. | 2021 | Details |
| A02870 | 34211180 | Nat Metab | Intestinal MYC modulates obesity-related metabolic dysfunction. | 2021 | Details |
| A02872 | 34211098 | Commun Biol | Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance. | 2021 | Details |
| A02882 | 34206460 | Int J Mol Sci | Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. | 2021 | Details |
| A02883 | 34206404 | Int J Mol Sci | Endothelial Progenitor Cells Dysfunctions and Cardiometabolic Disorders: From Mechanisms to Therapeutic Approaches. | 2021 | Details |
| A02886 | 34205674 | Int J Mol Sci | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart. | 2021 | Details |
| A02893 | 34204225 | Entropy (Basel) | Assessment of Classification Models and Relevant Features on Nonalcoholic Steatohepatitis Using Random Forest. | 2021 | Details |
| A02895 | 34203484 | Int J Mol Sci | Fructose and the Liver. | 2021 | Details |
| A02896 | 34203342 | Metabolites | Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02899 | 34202667 | Biomolecules | The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A02906 | 34201382 | Nutrients | Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches. | 2021 | Details |
| A02915 | 34199317 | Int J Mol Sci | Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. | 2021 | Details |
| A02918 | 34199237 | Diagnostics (Basel) | Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study. | 2021 | Details |
| A02923 | 34198853 | Int J Mol Sci | The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity. | 2021 | Details |
| A02931 | 34192792 | Horm Metab Res | Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome. | 2021 | Details |
| A02933 | 34192533 | Cell Rep | Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release. | 2021 | Details |
| A02934 | 34192532 | Cell Rep | A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity. | 2021 | Details |
| A02940 | 34190318 | J Clin Endocrinol Metab | Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes. | 2021 | Details |
| A02946 | 34188506 | Diabetes Metab Syndr Obes | Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study. | 2021 | Details |
| A02950 | 34187125 | J Complement Integr Med | Influence of irisin on diet-induced metabolic syndrome in experimental rat model. | 2021 | Details |
| A02955 | 34185201 | Inflammopharmacology | Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. | 2021 | Details |
| A02957 | 34184611 | Ann Med | Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016. | 2021 | Details |
| A02959 | 34184286 | J Food Biochem | Buchholzia coriacea seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease. | 2021 | Details |
| A02960 | 34183740 | Sci Rep | Circulating branch chain amino acids and improvement in liver fat content in response to exercise interventions in NAFLD. | 2021 | Details |
| A02964 | 34183247 | J Diabetes Complications | Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2021 | Details |
| A02983 | 34174062 | J Gastrointestin Liver Dis | The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02992 | 34171492 | Pharmacol Res | Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview. | 2021 | Details |
| A02995 | 34171397 | J Ethnopharmacol | Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway. | 2021 | Details |
| A03002 | 34168429 | Drug Des Devel Ther | Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats. | 2021 | Details |
| A03013 | 34164242 | Cureus | Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article. | 2021 | Details |
| A03016 | 34162924 | Sci Rep | Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. | 2021 | Details |
| A03019 | 34161185 | Autophagy | Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. | 2021 | Details |
| A03025 | 34159710 | Int J Clin Pract | Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): A case-control study. | 2021 | Details |
| A03040 | 34155798 | Liver Int | Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity? | 2021 | Details |
| A03056 | 34152053 | J Sleep Res | Metabolic dysfunction in OSA: Is there something new under the sun? | 2021 | Details |
| A03060 | 34149286 | Clin Exp Gastroenterol | Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease? | 2021 | Details |
| A03063 | 34147036 | Semin Liver Dis | Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials. | 2021 | Details |
| A03067 | 34144391 | Redox Biol | Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules. | 2021 | Details |
| A03070 | 34142516 | J Pediatr Endocrinol Metab | Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis. | 2021 | Details |
| A03075 | 34141709 | Front Cell Dev Biol | New Insights Into the Role of Autophagy in Liver Surgery in the Setting of Metabolic Syndrome and Related Diseases. | 2021 | Details |
| A03086 | 34136497 | Front Med (Lausanne) | Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents. | 2021 | Details |
| A03100 | 34131333 | Nat Rev Endocrinol | Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. | 2021 | Details |
| A03104 | 34129693 | Hepatology | Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A03106 | 34129252 | J Gastroenterol Hepatol | The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03110 | 34126247 | Endocr Pract | High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency. | 2021 | Details |
| A03131 | 34118476 | Mol Metab | Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH. | 2021 | Details |
| A03132 | 34118361 | Peptides | A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis. | 2021 | Details |
| A03146 | 34114325 | EMBO Rep | SCFJFK is functionally linked to obesity and metabolic syndrome. | 2021 | Details |
| A03163 | 34106786 | Am J Physiol Cell Physiol | Impaired Ca2+ signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment. | 2021 | Details |
| A03177 | 34099584 | J Physiol Pharmacol | Acute responses of hepatic fat content to consuming fat, glucose and fructose alone and in combination in non-obese non-diabetic individuals with non-alcoholic fatty liver disease. | 2021 | Details |
| A03178 | 34099068 | Hum Genomics | Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences. | 2021 | Details |
| A03195 | 34094026 | Iran J Basic Med Sci | The therapeutic effects of berberine plus sitagliptin in a rat model of fatty liver disease. | 2021 | Details |
| A03196 | 34093184 | Front Pharmacol | Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation. | 2021 | Details |
| A03212 | 34088068 | Sci Total Environ | Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis. | 2021 | Details |
| A03213 | 34087824 | Medicine (Baltimore) | Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials. | 2021 | Details |
| A03217 | 34083664 | Sci Rep | Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH. | 2021 | Details |
| A03219 | 34083525 | Nat Commun | Perilipin 5 links mitochondrial uncoupled respiration in brown fat to healthy white fat remodeling and systemic glucose tolerance. | 2021 | Details |
| A03226 | 34081289 | Hepatol Int | Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease. | 2021 | Details |
| A03231 | 34078528 | BMB Rep | Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway. | 2021 | Details |
| A03232 | 34078383 | J Transl Med | Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4. | 2021 | Details |
| A03235 | 34077443 | PLoS One | Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes. | 2021 | Details |
| A03238 | 34074988 | Eur J Gastroenterol Hepatol | Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults. | 2022 | Details |
| A03245 | 34073834 | Int J Mol Sci | P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice. | 2021 | Details |
| A03257 | 34069012 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. | 2021 | Details |
| A03259 | 34068699 | J Clin Med | Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate? | 2021 | Details |
| A03280 | 34062716 | Int J Mol Sci | Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. | 2021 | Details |
| A03291 | 34058224 | Metabolism | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2021 | Details |
| A03296 | 34056769 | Phytother Res | Molecular updates on berberine in liver diseases: Bench to bedside. | 2021 | Details |
| A03310 | 34049870 | BMJ Open Diabetes Res Care | Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes. | 2021 | Details |
| A03321 | 34046015 | Front Endocrinol (Lausanne) | Epigenetics of Hepatic Insulin Resistance. | 2021 | Details |
| A03322 | 34046014 | Front Endocrinol (Lausanne) | Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice. | 2021 | Details |
| A03332 | 34040583 | Front Endocrinol (Lausanne) | Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. | 2021 | Details |